EcoDrugPlus

Opioid Receptor Kappa 1

Ensembl ID : ENSSTUG00000038647
Gene Symbol: OPRK1
3 Cross references
192 Possible Orthologues:

Opioid Receptor, Kappa 1

Ensembl ID : ENSSTUG00000007346
Gene Symbol: OPRK1
1 Cross references
197 Possible Orthologues:

Oxysterols Receptor Lxr-Alpha-Like

Ensembl ID : ENSSTUG00000011589
Gene Symbol: LOC115167550
3 Cross references
384 Possible Orthologues:

Oxysterols Receptor Lxr-Alpha-Like

Ensembl ID : ENSSTUG00000005146
Gene Symbol: LOC115202857
3 Cross references
385 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSSTUG00000042286
Gene Symbol: OXTR
3 Cross references
177 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSSTUG00000009937
Gene Symbol: OXTR
3 Cross references
177 Possible Orthologues:

Parathyroid Hormone/parathyroid Hormone-Related Peptide Receptor-Like

Ensembl ID : ENSSTUG00000049940
Gene Symbol: LOC115169570
3 Cross references
190 Possible Orthologues:

Parathyroid Hormone/parathyroid Hormone-Related Peptide Receptor-Like

Ensembl ID : ENSSTUG00000012099
Gene Symbol: LOC115157207
3 Cross references
190 Possible Orthologues:

Permeability Factor 2-Like

Ensembl ID : ENSSTUG00000004785
Gene Symbol: LOC115171360
2 Cross references
176 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSSTUG00000022360
Gene Symbol: PPARD
3 Cross references
386 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSSTUG00000033713
Gene Symbol: PPARD
1 Cross references
345 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSSTUG00000045707
Gene Symbol: PPARD
3 Cross references
345 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).